These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25252449)

  • 1. [The newest perspectives on the treatment of glioblastoma multiforme].
    Cholewa H; Duda K; Łabuzek K; Okopień B
    Pol Merkur Lekarski; 2014 Aug; 37(218):119-23. PubMed ID: 25252449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
    Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
    J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
    Bambury RM; Morris PG
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standards of care and novel approaches in the management of glioblastoma multiforme.
    Hottinger AF; Stupp R; Homicsko K
    Chin J Cancer; 2014 Jan; 33(1):32-9. PubMed ID: 24384238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma multiforme: overview of current treatment and future perspectives.
    Anton K; Baehring JM; Mayer T
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):825-53. PubMed ID: 22794286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab for the treatment of glioblastoma.
    Chowdhary S; Chamberlain M
    Expert Rev Neurother; 2013 Aug; 13(8):937-49. PubMed ID: 23952194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of avastin in the management of recurrent glioblastoma.
    Sweet JA; Feinberg ML; Sherman JH
    Neurosurg Clin N Am; 2012 Apr; 23(2):331-41, x. PubMed ID: 22440876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics and pathways of Avastin for the treatment of glioblastoma multiforme.
    Spasic M; Chow F; Tu C; Nagasawa DT; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):417-27. PubMed ID: 22748654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment possibilities in patients with glioblastoma multiforme].
    Naydenov E; Tzekov C; Bussarsky V; Nachev S; Tzekova V; Hadjieva T
    Khirurgiia (Sofiia); 2010; (4-5):36-41. PubMed ID: 21972682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab in glioblastoma multiforme.
    Specenier P
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):9-18. PubMed ID: 22149428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic approaches in glioblastomas].
    Le Guilloux J; Carpentier AF
    Rev Neurol (Paris); 2008; 164(6-7):554-9. PubMed ID: 18565354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on bevacizumab and other angiogenesis inhibitors for brain cancer.
    Rinne ML; Lee EQ; Nayak L; Norden AD; Beroukhim R; Wen PY; Reardon DA
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):137-53. PubMed ID: 23668489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapies in glioblastoma multiforme.
    McNamara MG; Mason WP
    Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
    Cabrera AR; Cuneo KC; Desjardins A; Sampson JH; McSherry F; Herndon JE; Peters KB; Allen K; Hoang JK; Chang Z; Craciunescu O; Vredenburgh JJ; Friedman HS; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):873-9. PubMed ID: 23725997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab as first-line therapy for glioblastoma.
    Piccioni D; Lai A; Nghiemphu P; Cloughesy T
    Future Oncol; 2012 Aug; 8(8):929-38. PubMed ID: 22894667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.
    Chinot OL
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1413-27. PubMed ID: 23249106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-angiogenic strategies in glioblastoma].
    Guillamo JS
    Rev Neurol (Paris); 2011 Oct; 167(10):662-7. PubMed ID: 21889779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for intracranial gliomas.
    Tanaka S; Shin M; Mukasa A; Hanakita S; Saito K; Koga T; Saito N
    Neurosurg Clin N Am; 2013 Oct; 24(4):605-12. PubMed ID: 24093578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
    Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.